All Updates

All Updates

icon
Filter
Product updates
Devyser wins tender for supplying thalassemia screening product to Instituto Giannina Gaslini
Precision Medicine
May 27, 2024
This week:
M&A
Funding
TravelPerk raises USD 135 million in debt funding for expansion; acquires AmTrav
Travel Tech
Yesterday
Product updates
Apple announces Apple Pay Later shutdown
Buy Now, Pay Later
Jun 17, 2024
Management news
Velo3D appoints Brad Kreger as permanent CEO
Additive Manufacturing
Jun 17, 2024
Partnerships
Perplexity partners with SoftBank for AI search engine promotion in Japan
Generative AI Applications
Jun 17, 2024
Product updates
Runway launches Gen-3 Alpha for generating video clips
Generative AI Applications
Jun 17, 2024
Product updates
Adobe integrates Firefly into Acrobat with chat support across multiple documents in Acrobat AI Assistant
Generative AI Applications
Jun 17, 2024
Funding
Amplify Life raises USD 20 million in Series B to expand product suite
InsurTech: Personal Lines
Jun 17, 2024
Funding
Tinybird raises USD 30 million in Series B funding to improve real-time data analytics platform
Data Infrastructure & Analytics
Jun 17, 2024
Partnerships
The EVERY Company collaborates with Grupo Palacios to develop hen-less omelets
Plant-based Dairy & Egg
Jun 17, 2024
Partnerships
Believer Meats partners with AGWA to propel cultivated meat industry in MENA region
Cell-cultured Meat
Jun 17, 2024
Precision Medicine

Precision Medicine

May 27, 2024

Devyser wins tender for supplying thalassemia screening product to Instituto Giannina Gaslini

Product updates

  • Devyser has secured a tender for its NGS product, Devyser Thalassemia, a screening test for diagnosing thalassemia. The tender was awarded by Istituto Giannina Gaslini in Genoa and is valid for two years. The value of the transaction amounted to approximately 3.5 million SEK (USD 3.3 million).

  • The partnership entails a two-year supply agreement for Devyser’s thalassemia NGS product, allowing the company to penetrate the Italian market. The company claims that the test can be used in any laboratory running genetic testing or large-scale mutation screening. 

  • Sweden-based Devyser Diagnostics specializes in the development, manufacture, and sale of genetic testing kits. The company focuses on providing diagnostic solutions for complex DNA testing used in areas such as oncology, hematology, reproductive health, cystic fibrosis, cardiovascular diseases, and post-transplantation monitoring.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.